TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
458 pharmaceutical companies double voting commitment books have problems or been kicked out of the liaoning market!
 
Author:中国铭铉 企划部  Release Time:2017-9-14 10:34:54  Number Browse:925
 
Medical network - on September 14, on September 12, the liaoning provincial government procurement center "about once again remind relevant enterprises submitted drug purchase" two votes "pledge notice notice, there are 458" two votes "drug firms pledge has a problem.

▍ ultimatum, disqualification in 10 days

According to understand, implement the "two votes" is the production and distribution enterprises to participate in the activities of drug centralized purchasing in liaoning province of access conditions, failure to submit the "two votes" pledge of enterprise, it will suspend its participation in drug centralized purchasing activities in liaoning province.

According to notify the content, there are 143 drug firms "two votes" pledge is unqualified, there were 315 drug companies have not yet submitted "two votes" pledge, the deadline for September 22, 2017, exceed the time limit still not upload or audit unqualified, hang on production enterprise to suspend all of its net product qualification of netting, cancel the distribution of all drugs to the distribution enterprise qualification.

Actually, not only is the liaoning province, at present many provinces nationwide are centralized purchasing drugs to carry out the two votes before, added a submit "two votes" pledge, the purpose is to supervise the production and distribution enterprises better execution of two votes.

In July, for example, the jilin provincial drug production center announced that 870 pharmaceutical companies had been notified of the failure to pay two voting contracts. According to the requirements, the enterprises that did not submit the letter of commitment within the stipulated time are deemed not to implement the "two-ticket" and "drug online procurement" policy of jilin province. From August 1, we will stop the online trading qualification of all drugs in the relevant zhongbiao (hang network) enterprises, and the distribution enterprises of relevant distribution enterprises in the provincial public medical institutions.

▍ why so many enterprise is not in accordance with the provisions, submit a letter of commitment?

How to say that, did not press the regulation to submit the undertaking book, seems small, but it is a matter that the production enterprise and the distribution enterprise can base in the province. There is no "two-ticket" undertaking, which is equal to the market of the corresponding province.

Now that it's so serious, why do so many drug companies appear in the notification of ultimatums?

The author ventured to guess that it would not be a production enterprise, or a distribution company, which is trying to give up a provincial market in this way?

Everyone knows that there is a bidding season, and there is a "killer" price linkage, and some companies will choose to abandon the market in the price depression. From the point of view of maintaining price in the enterprise, it is also common to give up some market and lose the car.

However, the waste standard always has risks, some provinces will deduct margin, put in bad record and so on. So, it seems, the new focus on purchasing new drugs has added to the requirement for the "two-ticket" commitment, which seems to give businesses a better way to find a better alternative.

Think about it, if because the price, capacity and other reasons can't normal delivery, in most provinces are light pass mark, cancel the bid qualification, deduct the performance bond, or into the bad record, cancel the enterprise all products in the province of the bidding qualification, even was kicked out of the province's market for two years.

Is it worth a lot to not submit the "two-ticket" commitment to the above? After all, it's only a chance to win.
 
Previous article:The regulations on the management of commercial bribery in Shanghai pharmaceutical purchase and marketing
Next article:A list of 22 drug clinical trial data self-check registration applications
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号